Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Donor-transmitted extramedullary acute myeloid leukaemia after living donor kidney transplantation.
Ghandili S, Kluger MA, Leitner T, Grahammer F, Kirchner L, Modemann F, Achilles EG, Kreipe HH, Klein J, Steinemann D, Wolschke C, Fischer L, Bokemeyer C, Fiedler W, Huber TB, Alsdorf WH, Mahmud M. Ghandili S, et al. Among authors: alsdorf wh. Br J Haematol. 2022 Jul;198(1):199-202. doi: 10.1111/bjh.18194. Epub 2022 Apr 15. Br J Haematol. 2022. PMID: 35428972 Free PMC article. No abstract available.
Retrospective analysis of three induction chemotherapy regimens in acute myeloid leukemia including CPX-351, cytarabine/daunorubicin with and without the addition of cladribine.
Klingler F, Alsdorf WH, Ghandili S, Wolschke C, Brauneck F, Bokemeyer C, Fiedler W, Modemann F, Karagiannis P. Klingler F, et al. Among authors: alsdorf wh. Leuk Lymphoma. 2022 Nov;63(11):2645-2651. doi: 10.1080/10428194.2022.2092855. Epub 2022 Jul 5. Leuk Lymphoma. 2022. PMID: 35787724
Current pharmacotherapy for testicular germ cell cancer.
Alsdorf W, Seidel C, Bokemeyer C, Oing C. Alsdorf W, et al. Expert Opin Pharmacother. 2019 May;20(7):837-850. doi: 10.1080/14656566.2019.1583745. Epub 2019 Mar 8. Expert Opin Pharmacother. 2019. PMID: 30849243 Review.
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial.
Mackensen A, Haanen JBAG, Koenecke C, Alsdorf W, Wagner-Drouet E, Borchmann P, Heudobler D, Ferstl B, Klobuch S, Bokemeyer C, Desuki A, Lüke F, Kutsch N, Müller F, Smit E, Hillemanns P, Karagiannis P, Wiegert E, He Y, Ho T, Kang-Fortner Q, Schlitter AM, Schulz-Eying C, Finlayson A, Flemmig C, Kühlcke K, Preußner L, Rengstl B, Türeci Ö, Şahin U. Mackensen A, et al. Among authors: alsdorf w. Nat Med. 2023 Nov;29(11):2844-2853. doi: 10.1038/s41591-023-02612-0. Epub 2023 Oct 23. Nat Med. 2023. PMID: 37872225 Free PMC article. Clinical Trial.
27 results